1 In 3 of Your Patients Has Drug-Resistant Epilepsy¹

The rate of DRE has not been significantly reduced over the last 20 years despite the entry of new antiepileptic drugs (AEDs) with unique MOAs³

Drug-Resistant Epilepsy (DRE) is when a patient fails on 2 appropriately chosen and tolerated (whether as monotherapy or as combination) treatments.²

Epilepsy Population (seizure freedom rates)³

The cost of doing nothing can equal uncontrolled seizures and more.

DRE requires a comprehensive treatment for a complex disease.

Treatment options and treatment goals^2,4,5

New strategies are needed to help patients with DRE, as simply extending the use of AEDs is not always appropriate.

References

1. Mohanraj R, et al. Eur J Neurol. 2006;13:277-282. 2. Kwan P, et al. Epilepsia. 2010;51(6):1069-1077. 3. Brodie MJ. Epilepsia. 2013;54:5-8. 4. Jobst B, Epilepsia, 209; 50(Suppl 8) 61-56 5. Kossoff et al, Epilepsia, 2007; 48; 77-81 6. Kwan P et al. Epilepsia. 2009; 57-62, 7. Gilliam. Neurology. 2002; S9-S19, 8. Faught et al. Epilepsia. 2009; 501-509

1 In 3 of Your Patients Has Drug-Resistant Epilepsy1

The rate of DRE has not been significantly reduced over the last 20 years despite the entry of new antiepileptic drugs (AEDs) with unique MOAs3

Epilepsy Population (seizure freedom rates)3